JP Stock MarketDetailed Quotes
4565 Nxera Pharma
- 1298
- -43-3.21%
20min DelayMarket Closed Sep 13 15:00 JST
116.69BMarket Cap-14888P/E (Static)
1335High1287Low766.90KVolume1330Open1341Pre Close1.00BTurnover182652wk High1.16%Turnover Ratio89.90MShares126552wk Low-114.56EPS TTM85.69BFloat Cap6545Historical HighLossP/E (Static)66.02MShs Float23Historical Low-87.18EPS LYR3.58%Amplitude--Dividend TTM1.69P/B100Lot Size--Div YieldTTM
About Nxera Pharma Company
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein-Coupled Receptors (“GPCRs”).
Company Profile
Symbol4565
Company NameNxera Pharma
Founded1990-06-22
MarketTSE Prime
Employees364
Fiscal Year Ends12-31
AddressMidtown East 9-7-2 Akasaka Minato-ku
Zip Code107-0052
Phone03-5962-5718
Websitesoseiheptares.com
Company Executives
- Name
- Position
- Salary
- Christopher Cargill
- Director, President and Chief Executive Officer
- --
- Shinichi Tamura
- Chairman of the Board
- --
- Miwa Seki
- Independent Director
- --
- Noriaki Nagai
- Independent Director
- --
- David Roblin
- Independent Director
- --
- Eiko Tomita
- Independent Director
- --
- Tomohiro Tohyama
- Independent Director
- --
- Rolf Soderstrom
- Independent Director
- --
- Kuniaki Kaga
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data